NasdaqCM - Nasdaq Real Time Price USD
Elicio Therapeutics, Inc. (ELTX)
5.10
-0.12
(-2.30%)
As of 10:33:03 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-37,068
-37,068
-32,694
-22,179
-23,939.05
Investing Cash Flow
-84
-84
-32
-654
-525.36
Financing Cash Flow
42,321
42,321
38,613
21,202
19,393.57
End Cash Position
19,492
19,492
14,301
8,414
10,044.51
Capital Expenditure
-87
-87
-66
-654
-525.36
Issuance of Capital Stock
5,635
5,635
6,999
21,120
5,046.68
Issuance of Debt
19,727
19,727
10,000
--
14,470
Repayment of Debt
--
--
--
--
-437.99
Repurchase of Capital Stock
--
--
-150
--
--
Free Cash Flow
-37,155
-37,155
-32,760
-22,833
-24,464.40
12/31/2021 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IVA Inventiva S.A.
3.7800
-1.31%
SER Serina Therapeutics, Inc.
6.23
+7.77%
AMPE Ampio Pharmaceuticals, Inc.
0.0217
-2.33%
688177.SS Bio-Thera Solutions, Ltd.
21.72
-1.54%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
IVEVF Inventiva S.A.
2.2800
0.00%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
NXOA.BE Nicox SA
0.2275
+0.66%
GON.DU Geron Corp
1.2080
-1.31%